Thermo Fisher Scientific is the world leader in serving science. The company is the largest provider of analytical instruments, equipment, reagents and consumables, software and services for research, analysis discovery, and diagnostics.
Thermo Fisher Scientific is the world leader in serving science. The company is the largest provider of analytical instruments, equipment, reagents and consumables, software and services for research, analysis discovery, and diagnostics. Producing an annual revenue rate of more than $9 billion, Thermo Fisher serves over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environment, industrial quality and process control settings.
The company was founded in 1956 by Dr. George Hastopoulos. Since its inauguration, Thermo Fisher Scientific has been committed to maintaining a steady level of strategic growth. During its 50-year history, the company has completed acquisitions of some of the leading providers in the industry including Kendro Laboratory Products, Finnigan, and Nicolet. Most recently, the company has completed its merger with Fisher Scientific. The new Thermo Scientific brand represents a union of two leaders in scientific discovery: Thermo Electron and Fisher Scientific. The merger has enabled the company to provide its world-class offerings of equipment, consumables and reagents to more industries with a broader portfolio than ever before.
Thermo Fisher Scientific's analytical instrumentation products are used primarily in laboratory and industrial settings and incorporate a range of techniques, all of which can be combined with a range of accessories, consumables, software, special reference databases, services and support, to provide a complete solution. The company's offerings fall into two main categories, Life and Laboratory Sciences and Measurement and Control.
Looking forward, the company remains committed to its development of scientific instruments and technology, placing a strong focus on research and development.
Congratulations to LCGC on their 25th anniversary.
Greg Herrema
Greg Herrema
President of Scientific Instruments
Thermo Fisher Scientific
Determining Neurotransmitters in Spinal Cords with UHPLC
February 18th 2025Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing neurotransmitters (NTs) in rat spinal cord tissue. Ultra-high performance liquid chromatography-triple quadrupole tandem mass spectrometry (UHPLC-QqQ-MS/MS) in conjunction with ultra-ionic liquid dispersive liquid-liquid microextraction (UA-MIL-DLLME) were used to extract NTs for analysis.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Revolutionizing LC-MS with Next-Gen Separation for Cyclic Peptide Analysis
February 17th 2025Cyclic peptides, known for their stability and high specificity, are promising therapeutic agents in the fight against cancer, infections, and autoimmune diseases. However, developing effective cyclic peptides presents numerous challenges, including poor pharmacokinetics, efficacy, and toxicity. Traditional methods like liquid chromatography tandem-mass spectrometry (LC-MS/MS) often struggle with resolving isomeric linear peptide metabolites, posing significant risks in safety, efficacy, and regulatory approval. In this paper, Komal Kedia, PhD, will share how she leveraged MOBIE’s high-resolution ion mobility-mass spectrometry (IM-MS) system to achieve a 72% reduction in run times, 200% greater resolving power, and enhanced accuracy in identifying “soft spots” prone to enzymatic degradation.